<?xml version="1.0" encoding="ISO-8859-1"?>

<?xml-stylesheet type="text/css" href="https://www.webwire.com/includes/rssstyle.css"?>

<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
  
  <!-- Issuers of news/press releases and NOT WebWire are solely responsible for the accuracy of the content. -->



    <title>WebWire | News by Industry : Biotechnology</title>
    <link>https://www.webwire.com/</link>
    <description>Biotechnology News by WebWire</description>
    <language>en-US</language>
    <copyright>Copyright &#169; 2026 WebWire. All Rights Reserved.</copyright>
    <ttl>15</ttl>
    <lastBuildDate>Wed, 8 Jul 2026 11:49:20 EDT</lastBuildDate>
	<image>
      <title>WebWire | News by Industry : Biotechnology</title>
      <width>140</width>
      <height>32</height>
      <link>https://www.webwire.com/</link>
      <url>https://www.webwire.com/imgs/webwire_logo_140x32.gif</url>
    </image>
	

  <item>
     <title>Katalyze AI Raises $10.5M to Build the Agentic Operating System for Pharmaceutical Companies</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=357045</link>
     <pubDate>Mon, 6 Jul 2026 09:50:49 EDT</pubDate>
     <description><![CDATA[<p>  Katalyze AI, the agentic operating system for pharmaceutical companies, today announced $10.5 million in seed funding led by Bonfire Ventures, along with Inovia Capital, Ripple Ventures, Alumni Ventures, and leading angel investors including Gokul Rajaram and Farzad Soleimani. Katalyze&#39;s platform lets any scientist, engineer, or analyst in a biopharma company build teams of agents that take on real engineering, scientific, and manufacturing work. -   -   Why Now: The Opportunity to Put Agents...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=357045">https://www.webwire.com/ViewPressRel.asp?aId=357045</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/81468/357045/357045-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID357045</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Symrise wins worldwide L&#39;Or�al Energy Award for circular hydrogen recycling that advances decarbonization in cosmetics</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=357004</link>
     <pubDate>Wed, 1 Jul 2026 09:34:40 EDT</pubDate>
     <description><![CDATA[<p> -    -  &#8226;  L&#39;Or�al honors &#8220;Closing the Hydrogen Loop&#8221; as a pioneering circular production model -  &#8226;  Reduces fresh hydrogen demand by around 80% and improves process efficiency at scale -  &#8226;  Supports reliable supply and lower carbon intensity for everyday cosmetic applications -    -   -    Symrise won the worldwide L&#39;Or�al Sustainable Sourcing 2026 Energy Award in the PIONEERING category for &#8220;Closing the Hydrogen Loop.&#8221; As part of the &#8220;Spread The Green Vibes&#8221; event, the award aims to inspire business...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=357004">https://www.webwire.com/ViewPressRel.asp?aId=357004</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/357004/357004-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID357004</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Telehealth and Medicine Today Publishes June 2026 Issue on AI, Market Shifts, and Care Transformation</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356849</link>
     <pubDate>Mon, 29 Jun 2026 08:00:00 EDT</pubDate>
     <description><![CDATA[<p> Telehealth and Medicine Today (THMT), a SCImago Q2 ranked journal, announces the release of its June 2026 issue, presenting a new collection of research, market intelligence, and expert perspectives at the forefront of telehealth, artificial intelligence, and digital health transformation. -   -   This issue convenes global contributors addressing real world implementation, emerging operational challenges, and the expanding role of AI in clinical and care delivery environments. Topics span ele...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356849">https://www.webwire.com/ViewPressRel.asp?aId=356849</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/356849/356849-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356849</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Symrise receives CDP&#39;s top &#8220;A&#8221; rating for sustainable supplier engagement and Scope 3 transparency</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356756</link>
     <pubDate>Thu, 25 Jun 2026 11:18:01 EDT</pubDate>
     <description><![CDATA[<p> -    -  &#8226; CDP recognizes supplier collaboration, climate action, and transparent data along the value chain -  &#8226; Responsible sourcing supports customers in reaching Scope 3 targets and strengthens sustainable supply chains -    -   -    Symrise has achieved the top &#8220;A&#8221; rating in CDP&#39;s Supplier Engagement Assessment (SEA). This places the company among the leaders in sustainable supplier engagement and shows how consistently it translates responsible sourcing into measurable customer value. Across the...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356756">https://www.webwire.com/ViewPressRel.asp?aId=356756</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356756/356756-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356756</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>L&#39;Or�al to acquire a majority stake in Innovist, a leading digital-first Indian personal care house of brands</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356462</link>
     <pubDate>Thu, 18 Jun 2026 08:30:31 EDT</pubDate>
     <description><![CDATA[<p> -    -  &#8226;   Strategic expansion in India:  This investment reinforces L&#39;Or�al&#39;s commitment to India and accelerates its strategy to scale and lead in one of the world&#39;s fastest-growing beauty markets. -   -   &#8226;   Highly complementary brand fit:  Innovist&#39;s digital-first brands naturally complement L&#39;Or�al&#39;s existing portfolio, bringing high-performing science-led products specifically tailored for Indian consumers -  &#8226;   Operational continuity:  Agreement retains the expertise of Innovist&#39;s founding...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356462">https://www.webwire.com/ViewPressRel.asp?aId=356462</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356462/356462-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356462</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>A tiny ingestible sensor can measure temperature from inside the body</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356315</link>
     <pubDate>Tue, 16 Jun 2026 08:00:21 EDT</pubDate>
     <description><![CDATA[<p> In a hospital or at home, temperatures are usually taken using an oral or forehead thermometer, but these do not always accurately reflect the core body temperature. Measuring core temperature from within the body could make it easier to determine whether someone is sick, and whether they&#39;re at risk of spiking a dangerous fever. -   -  To make it more feasible to obtain core body temperature measurements, MIT engineers have developed an ingestible sensor that can send continuous temperature up...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356315">https://www.webwire.com/ViewPressRel.asp?aId=356315</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356315/356315-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356315</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>Symrise successfully renews syndicated credit facility (RCF)</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356310</link>
     <pubDate>Tue, 16 Jun 2026 07:40:58 EDT</pubDate>
     <description><![CDATA[<p> Symrise AG has successfully refinanced its existing revolving credit facility (RCF) and increased the volume to &#8364;750 million. The increase underlines the confidence of the financing partners in the company&#39;s strong credit quality and at the same time expands financial flexibility and security for further growth. The facility has a maturity of five years with two one-year extension options and an additional &#8364;250 million increase option if required. The conditions are attractive against the...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356310">https://www.webwire.com/ViewPressRel.asp?aId=356310</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/356310/356310-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356310</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>CONV2X Announces Smart Technology Transformation in Healthcare &amp; Life Sciences Summit in New York City</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=356147</link>
     <pubDate>Mon, 15 Jun 2026 10:56:45 EDT</pubDate>
     <description><![CDATA[<p>  CONV2X Smart Technology Transformation in Healthcare &amp; Life Sciences, announced its annual two-day executive summit taking place October 29&#8211;30, 2026 at the Historic GE Building, ILR Conference Center, 570 Lexington Avenue, New York, NY. -   -  Themed  Beyond the Pilot, the conference addresses a defining challenge of 2026: healthcare implementation &#8212; deploying AI, telehealth, and smart technology at enterprise scale with measurable outcomes, sustainable economics, and sound governance. -   -   Op...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=356147">https://www.webwire.com/ViewPressRel.asp?aId=356147</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/54628/356147/356147-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID356147</guid>
     <dc:type>Article</dc:type>
  </item>
  <item>
     <title>3D-printed devices could streamline the production of drug-delivery microparticles</title>
     <link>https://www.webwire.com/ViewPressRel.asp?aId=355980</link>
     <pubDate>Tue, 9 Jun 2026 08:39:59 EDT</pubDate>
     <description><![CDATA[<p> MIT researchers have demonstrated a low-cost design of specialized electronic nozzles, called triaxial electrospray emitters, that could be used to manufacture time-release drug-delivery particles or self-healing materials efficiently and at scale. -   -  Triaxial electrospray emitters use electricity to precisely dispense three liquids from microscopic nozzles to generate a steady stream with three distinct fluid layers. The liquid forms multilayered droplets, which can solidify into layered...</p><p>Read the full story at <a href="https://www.webwire.com/ViewPressRel.asp?aId=355980">https://www.webwire.com/ViewPressRel.asp?aId=355980</a></p>]]></description>
     <media:thumbnail url="https://photos.webwire.com/prmedia/6/355980/355980-1-m.jpg" width="240" height="240" />
     <guid isPermaLink="false">WebWireID355980</guid>
     <dc:type>Article</dc:type>
  </item>

  </channel>
</rss>
